Stockreport

Candel Therapeutics strengthens balance sheet as lead cancer therapy advances [Yahoo! Finance]

Candel Therapeutics, Inc.  (CADL) 
PDF Candel Therapeutics Inc (NASDAQ:CADL) is advancing plans to bring its lead cancer immunotherapy toward potential commercialization, outlining new phase 3 trials and a p [Read more]